Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,895.10
+315.85 (20.00%)
At close: Sep 25, 2026
Bharat Parenterals Market Cap
Bharat Parenterals has a market cap or net worth of 13.06 billion as of September 25, 2026. Its market cap has increased by 45.82% in one year.
Market Cap
13.06B
Enterprise Value
14.25B
Revenue
3.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,895.10
ChartMarket Cap Chart
Since March 21, 2018, Bharat Parenterals's market cap has increased from 914.45M to 13.06B, an increase of 1,328.28%. That is a compound annual growth rate of 36.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 13.06B | 56.69% |
| Dec 31, 2025 | 8.34B | -12.96% |
| Dec 31, 2024 | 9.58B | 103.12% |
| Dec 29, 2023 | 4.71B | 148.91% |
| Dec 30, 2022 | 1.89B | -13.76% |
| Dec 31, 2021 | 2.20B | 8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syncom Formulations (India) | 18.88B |
| TTK Healthcare | 14.82B |
| Amrutanjan Health Care | 14.77B |
| Fermenta Biotech | 13.59B |
| Kopran | 13.10B |
| Lincoln Pharmaceuticals | 11.93B |
| Sudarshan Pharma Industries | 9.72B |
| Anuh Pharma | 9.36B |